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Background/aim: The aim of this study is to evaluate why dementia patients (DPs) are admitted to a palliative care center (PCC) and
which factors affect the length of stay (LOS) of DPs in the PCC, and to predict the course of the disease.
Materials and methods: The files of DPs were scanned retrospectively in the PCC between 2013 and 2016. Data related to age, sex, LOS,
symptoms, clinical conditions, comorbidities, and prognosis were recorded.
Results: The study included 85 DPs with a mean age of 84.1 ± 6.7 years. LOS was determined as a median of 15.0 days. While LOS
decreased due to age and cancer, it increased due to pressure injury. Although mortality was increased by LOS, it was decreased by
hypertension, mobilization, and percutaneous endoscopic gastrostomy. Among the DPs who were admitted to the PCC, the death rate
was 54.1% and the discharge rate was 45.9%.
Conclusion: It is concluded that adopting a palliative care approach eases symptom management. While this approach decreases the
burden of symptoms, it at the same time increases the quality of life of DPs and their families.
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1. Introduction
Increased life expectancy causes an increase in the
prevalence of chronic diseases such as dementia. There is
an ongoing increase in the number of dementia patients
(DPs) worldwide. It is predicted that the number of DPs
will double every 20 years (1), increasing from 46.8 million
in 2015 to 74.7 million in 2030 and reaching 131.5 million
in 2050 (2).
At present, dementia remains as an incurable disease,
which restricts the quality of lives (3). Dementia, which
affects memory, thinking, behavior, and the ability to
perform everyday activities, is a chronic or progressive
syndrome caused by various brain diseases (1). The
advanced stage of dementia, which causes loss of cognitive
function, may be accompanied by complex clinical
findings and severe symptoms (4,5). These symptoms have
a negative effect on the patients, their families, and those
around them (4). Palliative care (PC) focuses on improving
the quality of life of patients with life-restricting diseases
such as dementia, but unfortunately, many advanced-stage
DPs are unable to access PC services (6).
In the past, dementia care attracted little interest, but now
it has become a global agenda in the scopes of healthcare,
* Correspondence: drmetindincer@yahoo.com

education, social care, economics, politics, and research (7).
Together with an increase in the number of patients, the care
and problems associated with the treatment of DPs have
created a greater interest in PC for these patients (8).
In Turkey, the necessity of PC and the PC approach
for advanced-stage DPs with life-threatening conditions
are unknown. The aim of this study is to determine the
characteristics of DPs who were admitted to a palliative
care center (PCC) for PC and to find out factors affecting
the length of stay (LOS) and prognosis of DPs. This study,
the importance of which is to define PC requirements for
DPs, is an unprecedented research in this scope in Turkey.
2. Materials and methods
2.1. Ethics statement
The files of DPs who were admitted to the PCC for PC of
Ankara Ulus State Hospital between 1 January 2013 and
31 December 2016 were scanned retrospectively. The
study was approved by the Ankara Numune Training
and Research Hospital Ethics Committee (22.02.2017,
Approval No: E-17-1281). All these procedures were
performed in accordance with the principles of the
Declaration of Helsinki.
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2.2. Measurements
The data of DPs admitted to the PCC included the
following: age, sex, location prior to admission to the
PCC (home/hospital), dependence scale, symptoms
(shortness of breath, pain, nausea/vomiting, agitation),
comorbidities (hypertension (HT), diabetes mellitus
(DM), cerebrovascular event (CVE), chronic heart failure
(CHF), chronic obstructive pulmonary disease (COPD),
cancer), clinical conditions (mobilization, oral intake,
percutaneous endoscopic gastrostomy (PEG), pressure
injury (PI), pneumonia, fall history), and discharge (dead
or alive). The dependency scale is a scale that measures the
degree of support that the DP is in need of; the patients
are graded between 0 and 5 according to the scale. Level
0 includes patients who are independent and who have
normal life activities, while Level 5 is includes patients who
have the highest level of dependency (9). According to this
dependency scale, patients who use diapers, who have a
urinary catheter, who have feeding tubes, or who cannot
move by themselves are fully dependent (9). In other words,
they are Level 5 dependent patients. The dependency
levels used in this study were established according to the
information obtained from patient files. The data used in
the study were gathered from electronic patient records by
using Hospital Information Management System (HIMS)
software (Alpdata Co. Inc., Ankara, Turkey).
2.3 Statistical analysis
MS Excel 2007 and IBM SPSS Statistics 21.0 software
(IBM Corp., Armonk, NY, USA) were used for statistical
analyses, calculations, and graphs.
Necessary controls and corrections were made in
the data gathered from HIMS. Whether the continuous
variables (age and LOS) were in conformity with normal
distribution was examined graphically and with the
Shapiro–Wilk test. Normal distribution was observed for

the age variable but not LOS in the PCC. While descriptive
statistics for age were shown as the mean ± standard
deviation (SD), LOS in the PCC was demonstrated with the
median [interquartile range (IQR)]. Categorical variables
(sex, symptoms, clinical conditions, and comorbidities)
were shown as the number (n) and percentage (%).
The Mann–Whitney U test was used to examine
differences between LOS and the following variables:
symptoms, clinic conditions, and comorbidities. The
independent-samples t-test (Student’s t-test) was used
to compare age with the following variables: symptoms,
clinic conditions, and comorbidities. To determine the
factors that could affect mortality, the confidence interval
(CI) was calculated using the odds ratio (OR). Chi-square
test (χ2) was used to determine to distribution of clinical
conditions and comorbidities according to gender.
A multivariable linear regression model was established
to evaluate the factors affecting LOS. A binary logit
model was used to evaluate the factors on mortality. A
dummy dependent variable was used in this model: value
1 was given to the dummy dependent variable for those
who passed away and value 0 was given to the dummy
dependent variable for those who survived. P < 0.05 was
considered to be statistically significant. In this study,
those who were discharged were either alive or dead.
3. Results
Of 103 DPs admitted to the PCC of the Ankara Ulus
State Hospital between 1 January 2013 and 31 December
2016, 18 patients were excluded from the study: one had
incomplete records, nine had LOS of ≤2 days, and eight
had repeated admissions. Thus, a total of 85 patients were
included in the study.
Of 85 patients, there were 47 females (55.3%) and 38
males (44.7%), with a mean age of 84.1 ± 6.7 years: 39

Table 1. Demographic information and length of stay of patients.

Age* (years)

LOS** (days)

Variables

Min–max

Mean ± SD
Median (IQR)

Female (n = 47)

64–100

85.15 ± 7.38

Male (n = 38)

74–93

82.84 ± 5.51

Admitted from home (n = 39)

64–95

83.31 ± 6.81

Admitted from other clinics (n = 46)

73–100

84.80 ± 6.55

Female (n = 47)

3–116

17.0 (18.0)

Male (n = 38)

3–148

14.5 (25.0)

Admitted from home (n = 39)

3–148

17.0 (18.0)

Admitted from other clinics (n = 46)

3–116

15.0 (25.0)

*Mean ± standard deviation (SD). **Interquartile range (IQR). LOS: Length of stay.
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Statistical test
t/Z

P

t = 1.600

0.113

t = 1.031

0.306

Z = 0.933

0.351

Z = 0.079

0.937
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(45.9%) patients admitted to the PCC were from home
and 46 (54.1%) were transferred from another healthcare
institution. LOS in the PCC ranged from 3 to 148 days, with
a median of 15.0 days (IQR = 24.0) (Table 1). Neither sex
nor the origin of the patient (home or another healthcare
institution) was found to be effective on the age of the DP
or LOS (P > 0.05).
3.1. Comorbidities and clinical conditions
The most common symptoms of DPs admitted to the PCC
were shortness of breath (n = 46; 54.1%), pain (n = 14;
16.5%), nausea/vomiting (n = 13; 15.3%), and agitation (n
= 11; 12.9%). The most frequently observed comorbidities
in these patients were HT (n = 35; 41.2%), DM (n = 19;
22.4%), CVE (n = 29; 34.1%), CHF (n = 10; 11.8%), COPD
(n = 8; 9.4%), and cancer (n = 7; 8.2%). The most common
clinical conditions of DPs admitted to the PCC were
immobilization (n = 69; 81.28%), oral intake and PEG (n =
25; 29.4%), PI (n = 42; 49.4%), pneumonia (n = 14; 16.5%),
and falls (n = 10; 11.8%). The number of male patients
with complaints of falling was four times more than that of
females and a significant difference was observed between
the sexes with respect to falling (χ2 = 5.711; P = 0.017).
When all the other factors (age and clinical conditions)
were assumed to be fixed, male sex showed a higher risk of
hospital admittance with complaints of falling, with odds
ratio (OR) = 6.0 (95% CI = 1.19–30.22), when compared
with that of females. The rates of other clinical conditions
and comorbidities showed no differences according to sex
(P > 0.05) (Table 2).
3.2. LOS
According to the multivariable linear regression analysis
results, LOS as a variable had a statistically meaningful
association with age (z = –2.47; P = 0,016), cancer (z =
–2.10; P = 0.039), and PI (z = 2.98; P = 0.004). When
the P-value is accepted to be below 10% (P < 0.10), DM
can be accepted to be effective in the established model.
As variables such as age and cancer reduced LOS, PI
prolonged LOS. On the condition that the other variables
were constant, the period of hospitalization decreased by
1.07 days when the age of patient increased by 1 year. The
average LOS in patients with PI increased by 16.32 days.
On the contrary, the average LOS in patients with cancer
decreased by 21.1 days (Table 3).
3.3. Discharge and mortality status
It was determined that 39 (45.9%) of the DP admitted
to the PCC were discharged and 46 (54.1%) of them
died in the hospital. According to binary logit model
results, independent variables HT (z = –2.85; P = 0.004),
mobilization (z = –3.14; P = 0.002), and PEG (z = –2.13;
P = 0.033) were found to be statistically meaningful in
mortality. When the P-value is accepted to be below 10%
(P < 0.10), LOS and DM can be accepted to be effective in
the established model. The possibility of mortality risk in

DPs with HT decreased by 41.54% when compared with
DP without HT (marginal effect = –0.4154; OR = 0.1720).
Similarly, the possibility of mortality risk in DPs who were
mobile decreased by 30.43% compared with DPs who
were immobile (marginal effect = –0.3043; OR = 0.0596).
In addition, the results indicated that the possibility of
mortality risk of DPs with PEG decreased by 21.36% in the
PCC (marginal effect = –0.2136; OR = 0.2816) (Table 4).
4. Discussion
The reality that DPs are highly in need of PC was neglected
worldwide until 2000 and it has been on the agenda more
frequently in healthcare policies and in the literature due
to the fact that chronic diseases and dependencies of
elderly have increased in recent years (7,8). During the
advanced stage of dementia, the symptoms that reduce
the quality of life are studied in the literature (10–12). The
most frequent symptoms of DPs in the literature were pain
(52%), agitation (35%), and shortness of breath (35%)
and the same results have been found in this study (5).
In a study carried out in a nursing home on the clinical
course of DPs, among distressing symptoms, dyspnea at
46% was the most frequent symptom, and the second was
pain at 39% (13). Similar to the findings in the literature,
in this study comorbidities such as CHF and CVE were
observed in 24.6% and 15.7% of DPs, respectively (14).
In DPs the incidence of chronic and systematic diseases
is increasing (1,15). Since DPs gradually lose control of
managing systematic and chronic diseases such as HT and
DM, the burden of these diseases is becoming more and
more obvious (1,16).
It has been observed that the number of male patients
who complained about falling was four times more than
that of the female patients. The reason why male patients
fall more often than female patients is that male patients
lose both visual perception and walking ability much more
than female patients (17).
In this study it has also been observed that old age and
diagnosis of cancer in DPs reduced LOS while PI increased
LOS. In other studies, it was observed that old age and
cancer reduced LOS and increased mortality (7,18,19). If a
DP has PI, it shows that there is poor quality of care (4,20),
and consequently this patient is admitted to the PCC (21).
It is concluded that PI has no association with mortality,
but since a long time to cure it, PI prolongs the LOS (21).
It has also been observed that the rate of death was
lower in DPs with HT. The relationship between HT and
dementia is very complicated and HT is a risk factor for
dementia (22,23). Furthermore, HT is one of the diseases
that has been observed most frequently in DPs (15,23).
Since regulating blood pressure can diminish brain
function disorders it is thought that this can contribute to
prolongation of the lifespan (22,23).
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Table 2. Distribution of clinical conditions and comorbidities according to sex.
Variables

Conditions

Female
n

Male
%

N

Statistical test
%

χ2

p

0.105

0.949

0.061

0.805

0.023

0.879

2.904

0.088

1.553

0.213

0.533

0.465

0.612

0.434

0.817

0.366

0.128

0.720

1.463

0.226

0.011

0.918

0.007

0.932

0.007

0.933

1.828

0.176

0.115

0.735

0.190

0.663

5.711

0.017

Dependence scale
3 moderate

4

57.1

3

42.9

4 severe

4

50.0

4

50.0

5 severe

39

55.7

31

44.3

Absent

21

53.8

18

46.2

Present

26

56.5

20

43.5

Absent

39

54.9

32

45.1

Present

8

57.1

6

42.9

Absent

37

51.4

35

48.6

Present

10

76.9

3

23.1

Absent

39

52.7

35

47.3

Present

8

72.7

3

27.3

Symptoms on admission
Shortness of breath
Pain
Nausea/vomiting
Agitation
Comorbidities
HT
DM
CVE
CHF
COPD
Cancer

Absent

26

52.0

24

48.0

Present

21

60.0

14

40.0

Absent

35

53.0

31

47.0

Present

12

63.2

7

36.8

Absent

29

51.8

27

48.2

Present

18

62.1

11

37.9

Absent

42

56.0

33

44.0

Present

5

50.0

5

50.0

Absent

41

53.2

36

46.8

Present

6

75.0

2

25.0

Absent

43

55.1

35

44.9

Present

4

57.1

3

42.9

Absent

38

55.1

31

44.9

Present

9

56.3

7

43.8

Absent

33

55.0

27

45.0

Present

14

56.0

11

44.0

Absent

36

60.0

24

40.0

Present

11

44.0

14

56.0

Absent

23

53.5

20

46.5

Present

24

57.1

18

42.9

Absent

40

56.3

31

43.7

Present

7

50.0

7

50.0

Absent

45

60.0

30

40.0

Present

2

20.0

8

80.0

Clinical conditions
Mobilization
Oral nutrition
PEG
Pressure injury
Pneumonia
Fall

HT: Hypertension, DM: diabetes mellitus, CVE: cerebrovascular event, CHF: chronic heart failure, COPD: chronic obstructive
pulmonary disease, PEG: percutaneous endoscopic gastrostomy.
Values are given as number of cases (%).
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Table 3. Multivariate linear regression model results for length of stay.
Variables

Coefficient

Std. error

z

P

95% Confidence interval

Age

–1.0738

0.4346

–2.47

0.016

–1.9387

–0.2087

Diabetes mellitus

12.6479

6.8002

1.86

0.067

–0.8848

26.1806

Cancer

–21.1035

10.0691

–2.10

0.039

–41.1415

–1.0653

Pressure injury

16.3276

5.4781

2.98

0.004

5.4257

27.2293

R2 = 0.1740; F-test: test statistics value: 5.42; P: 0.0006.

Table 4. Binary logit model result for mortality.
Variables

Coefficient

Std. error

Odds
ratio

Marginal
effects

z

P

95% confidence interval

Length of stay

0.0194

0.0112

1.0196

0.2880

1.76

0.078

0.9978

1.0418

Hypertension

–1.7600

0.1062

0.1720

–0.4154

–2.85

0.004

0.0513

0.5767

Diabetes mellitus

1.2896

2.5777

3.6315

0.1652

1.82

0.069

0.9034

14.5978

Mobilization

–2.8199

0.0535

0.0596

–0.3043

–3.14

0.002

0.0103

0.3460

PEG

–1.2671

0.1672

0.2816

–0.2136

–2.13

0.033

0.0880

0.9019

Pseudo R2 = 0.2334; LR test: test statistics value: 27.36; degrees of freedom: 5; P: 0.0000.
PEG: Percutaneous endoscopic gastrostomy.

Campbell et al. (18) reported that functional status
affected mortality; in this study, the fact that patients were
mobile reduced the rate of mortality. DPs who took part
in this study were those who were in need of help from
other people, most of whom were fully dependent (n = 69,
81.2%).
Hendriks et al. (5) reported that dehydration/cachexia
at 38% was the most frequent reason for mortality in DPs.
In the present study, it was observed that 70.6% of DPs
did not have oral intake and 29.4% were nourished with
PEG. Suzuki et al. (24) reported that feeding with PEG
decreased mortality and it was also observed that feeding
with PEG decreased mortality in this study, although some
studies said that there was no evidence for the fact that
DPs who are fed with PEG survive longer than those who
are not (19,25).
In conclusion, as the human lifespan is steadily
increasing, there is a significant increase not only in chronic
diseases such as dementia but also in the necessity of PC.
The burden of DPs also increases in Turkey as observed
throughout the world. For better symptom management in
DPs, a PC approach should be used. The PC approach not

only decreases the burden of dementia but also increases
the quality of life of the patients and their families. Family
members are willing to hospitalize their DPs in Turkey
because the care of the majority of DPs is given by family
members. Also, family members are not in the position to
decide on the health condition of their patients.
The PCC where this study was carried out is a pioneer
of its kind in Turkey because it serves not only patients with
cancer but also those who have other ailments, whereas the
other PCCs deal only with a few types of disease. Patients’
families and caregivers are trained in how to give care and
how to live together with those patients in the PCC.
Although PC is beneficial for DPs, the importance of
PC can hardly be understood and the number of PCCs all
over the country is not adequate. Therefore, it is necessary
to conduct more studies to emphasize the need of PC for
DPs in Turkey.
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